Fertility patients vulnerable to social media overload of misleading data where evidence and algorithms collide
BEIJING, May 7, 2026 /PRNewswire/ -- Patient information overload dominated by misleading social media and marketing is causing patients experiencing infertility to have unrealistic expectations about treatment success often resulting in psychological distress. "Never before have patients had so much information on fertility medicine, and never before has so much of it...
Taimei Technology and C&R Research Announce Strategic Partnership to Build AI-Powered Clinical Trial Innovation
SEOUL, South Korea and SHANGHAI, May 7, 2026 /PRNewswire/ -- Taimei Technology (HK.02576), a leading AI-powered drug clinical development platform company, and C&R Research (A359090), a top-tier CRO in South Korea, signed an enterprise-level strategic partnership agreement, officially launching the development of an AI-based clinical trial operations system. Scene from the signing of the strategic cooperation agreement. Under...
USANA Hosts Inspiring Spa & Wellness Retreat to Empower Women Across Asia Pacific
Event centred around USANA's Celavive skincare brand and celebrating the accomplishments of USANA's female Brand Partners PHUKET, Thailand, May 7, 2026 /PRNewswire/ -- USANA successfully concluded its highly anticipated Celavive skincare spa and wellness retreat held at Club Med Phuket from April 22–24, 2026. This event brought together 79 top qualifying USANA...
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation
CAMBRIDGE, Mass., May 7, 2026 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the appointment of Dr. Josh Xiao as Chief Scientific Officer (CSO). Dr. Xiao will be based in both US and China and report directly to Dr....
Move towards global consensus guidelines on surrogacy with mounting concerns over human rights violations
BEIJING, May 7, 2026 /PRNewswire/ -- World leaders in assisted reproductive technology are finalising global consensus guidelines on minimal standards in surrogacy to address mounting concerns about severe human rights violations. The standards will attempt to tackle inconsistent or inadequate regulation of the practice, particularly in settings where there is disempowerment of women...
AID 2026 to Showcase Booming Opportunities in Silver Economy
SHANGHAI, May 7, 2026 /PRNewswire/ -- International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare, Shanghai 2026 (hereinafter referred to as AID 2026), widely recognized as China's leading event for the senior care and silver economy sectors, will be held on June 4–6 at Shanghai New International Expo Center (SNIEC), Halls W1–W5. Spanning over 60,000 square meters, the expo...
19.3% Weight Reduction, 16.5 cm Waist Circumference Decrease, SBP/DBP Reductions of 22.9/12.9 mmHg, 70.7 μmol/L Uric Acid Reduction, and 33.6% Triglyceride Reduction: BGM0504 Demonstrates Comprehensive Cardiometabolic Regulation Capabilities
SUZHOU, China, May 7, 2026 /PRNewswire/ -- Recently, BrightGene Bio-Medical Technology Co., Ltd. (hereinafter referred to as "BrightGene Bio-Medical " or "the Company") announced that its proprietary GLP-1 (glucagon-like peptide-1)/GIP (glucose-dependent insulinotropic polypeptide) dual receptor agonist, BGM0504 injection, has achieved positive topline results from a Phase III clinical trial (CTR20243983/NCT06704581) evaluating its efficacy and safety in participants with overweight or...
ABEC Expands Process Sciences Group to Strengthen Bioprocess Optimization Capabilities
BETHLEHEM, Pa., May 6, 2026 /PRNewswire/ -- ABEC, a global leader in bioprocess engineering solutions, announced the expansion of its Process Sciences group, expanding its ability to help biopharmaceutical manufacturers accelerate development, reduce risk, and improve productivity across the bioprocess lifecycle. The Process Sciences team integrates chemical and bioengineering expertise with...
Graphy Cements Role as ‘Digital Orthodontics Standard’ at AAO 2026, Accelerating Global Expansion
Through strategic participation at AAO 2026, Graphy strengthens its global footprint by delivering scalable SMA solutions and a unified digital platform to the North American orthodontic industry. Clinical Credibility Validated: Featured official invited lectures by world-renowned orthodontic experts. Ecosystem Growth: Strategic global partnerships formed to scale digital orthodontic integration. Next-Gen...
Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)
SUZHOU, China and MÖLNDAL, Sweden, May 6, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB ("Ribo", HKEX: 6938) today announced the achievement of a further milestone. This marks the third key milestone achieved in the research collaboration with Boehringer Ingelheim to discover novel therapies for liver...
